Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Teikoku Pharma patents

Patents where

Current Assignee

Name

Teikoku Pharma

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8979724 General medication disposal system	Patent 8979724 was granted and assigned to Teikoku Pharma on March, 2015 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	8979724	March 17, 2015
‌ US Patent 8445010 Abuse potential reduction in abusable substance dosage form	Patent 8445010 was granted and assigned to Teikoku Pharma on May, 2013 by the United States Patent and Trademark Office.		Teikoku Pharma	United States Patent and Trademark Office	8445010	May 21, 2013
‌ US Patent 9949935 Rivastigmine transdermal compositions and methods of using the same	Patent 9949935 was granted and assigned to Teikoku Pharma on April, 2018 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	9949935	April 24, 2018
‌ US Patent 8475837 Abuse potential reduction in abusable substance dosage form	Patent 8475837 was granted and assigned to Teikoku Pharma on July, 2013 by the United States Patent and Trademark Office.		Teikoku Pharma	United States Patent and Trademark Office	8475837	July 2, 2013
‌ US Patent 8062661 Methods and compositions for treating skin wounds	Patent 8062661 was granted and assigned to Teikoku Pharma on November, 2011 by the United States Patent and Trademark Office.		Teikoku Pharma	United States Patent and Trademark Office	8062661	November 22, 2011
‌ US Patent 10987342 Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine	Patent 10987342 was granted and assigned to Teikoku Pharma on April, 2021 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	10987342	April 27, 2021
‌ US Patent 9827207 Propynylaminoindan transdermal compositions	Patent 9827207 was granted and assigned to Teikoku Pharma on November, 2017 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	9827207	November 28, 2017
‌ US Patent 9597301 Propynylaminoindan transdermal compositions	Patent 9597301 was granted and assigned to Teikoku Pharma on March, 2017 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	9597301	March 21, 2017
‌ US Patent 9913812 Methods for the treatment of skin neoplasms	Patent 9913812 was granted and assigned to Teikoku Pharma on March, 2018 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	9913812	March 13, 2018
‌ US Patent 10918607 Propynylaminoindan transdermal compositions	Patent 10918607 was granted and assigned to Teikoku Pharma on February, 2021 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	10918607	February 16, 2021
‌ US Patent 8940786 Non-aqueous taxane nanodispersion formulations and methods of using the same	Patent 8940786 was granted and assigned to Teikoku Pharma on January, 2015 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	8940786	January 27, 2015
‌ US Patent 8463373 Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis	Patent 8463373 was granted and assigned to Teikoku Pharma on June, 2013 by the United States Patent and Trademark Office.		Teikoku Pharma	United States Patent and Trademark Office	8463373	June 11, 2013
‌ US Patent 9308195 Non-aqueous taxane formulations and methods of using the same	Patent 9308195 was granted and assigned to Teikoku Pharma on April, 2016 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	9308195	April 12, 2016
‌ US Patent 9017723 Propynylaminoindan transdermal compositions	Patent 9017723 was granted and assigned to Teikoku Pharma on April, 2015 by the United States Patent and Trademark Office.		Teikoku Pharma	United States Patent and Trademark Office	9017723	April 28, 2015
‌ US Patent 9144553 Compositions and methods for transdermal delivery of hormones and other medicinal agents	Patent 9144553 was granted and assigned to Teikoku Pharma on September, 2015 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	9144553	September 29, 2015
‌ US Patent 10022340 Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same	Patent 10022340 was granted and assigned to Teikoku Pharma on July, 2018 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	10022340	July 17, 2018
‌ US Patent 10188616 Topical sphingosine-1-phosphate receptor agonist formulations and methods of using the same	Patent 10188616 was granted and assigned to Teikoku Pharma on January, 2019 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	10188616	January 29, 2019
‌ US Patent 8609134 Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same	Patent 8609134 was granted and assigned to Teikoku Pharma on December, 2013 by the United States Patent and Trademark Office.		Teikoku Pharma	United States Patent and Trademark Office	8609134	December 17, 2013
‌ US Patent 9579296 Compositions and methods for transdermal delivery of hormones and other medicinal agents	Patent 9579296 was granted and assigned to Teikoku Pharma on February, 2017 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	9579296	February 28, 2017
‌ US Patent 9421356 Transdermal methods and systems for the delivery of corticosteroid compounds	Patent 9421356 was granted and assigned to Teikoku Pharma on August, 2016 by the United States Patent and Trademark Office.		Teikoku Pharma	United States Patent and Trademark Office	9421356	August 23, 2016
‌ US Patent 10357463 Rivastigmine transdermal compositions and methods of using the same	Patent 10357463 was granted and assigned to Teikoku Pharma on July, 2019 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	10357463	July 23, 2019
‌ US Patent 9339856 Transdermal patch disposal system	Patent 9339856 was granted and assigned to Teikoku Pharma on May, 2016 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	9339856	May 17, 2016
‌ US Patent 8790583 Transdermal patch disposal system	Patent 8790583 was granted and assigned to Teikoku Pharma on July, 2014 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	8790583	July 29, 2014
‌ US Patent 9205061 Propynylaminoindan transdermal compositions	Patent 9205061 was granted and assigned to Teikoku Pharma on December, 2015 by the United States Patent and Trademark Office.	Teikoku Pharma	Teikoku Pharma	United States Patent and Trademark Office	9205061	December 8, 2015
‌ US Patent 8535711 Medication disposal system	Patent 8535711 was granted and assigned to Teikoku Pharma on September, 2013 by the United States Patent and Trademark Office.		Teikoku Pharma	United States Patent and Trademark Office	8535711	September 17, 2013

Results per page:

41 results

0 selected

41 results

0 selected